We're developing a gamechanger in the world of injectables.
|
Hi [HCP First Name],
Thank you again for your interest in HArmonyCa®.
As more patients present with early jowling, cheek sagging, and loss of firmness, the challenge often is not volume alone. Many need support for both structure and skin quality. That is where HArmonyCa® creates interest.
HArmonyCa® delivers immediate lift from HA while CaHA stimulates collagen regeneration, helping restore skin's natural bounce in a single treatment.
|
|
Why HArmonyCa® stands out:
|
|
Instant lift with sustained collagen regeneration to restore skin's
natural bounce 1,2
|
|
Two mechanisms. One syringe.
Predictable results 3
|
|
Well-tolerated treatment with minimal downtime 4
|
|
|
This dual-action approach is designed for patients where filler alone is not quite enough, and where combining multiple treatments adds complexity. With HArmonyCa®, you get
immediate structural
lift from HA, while CaHA supports collagen production and extracellular matrix renewal over time. 5, 6.
|
|
It is a practical option for patients with:
|
- Mild to moderate lateral cheek sagging
- Early jowling
- Loss of firmness and elasticity
- Facial skin laxity where the goal is to restore natural bounce
|
|
|
What also makes HArmonyCa® compelling is its simplicity. Rather than manually layering or
mixing products, you deliver both mechanisms in one ready-to-use injectable. One syringe.
One treatment approach. More consistency in how you treat the right patient. 1-3
|
|
|
|
|
I am here to support and can help you identify ideal first-patient profiles or support your next order through Allergan Direct.
Best,
[Sales Rep Name]
[Title]
[Contact Information]
|
|
|
|
Manage your preferences
|
Unsubscribe
|
View in browser
References:
- Allergan Aesthetics. HArmonyCa® Lidocaine DFU. November 14, 2025.
- Hee C, et al. Dermatol Surg. 2015;41:S373-381.
- Coleman SR, Grover R. Aesthetic Surg J. 2006;26(1S):S4-9.
- Urdiales-Gálvez F et al., J Cosmet Dermatol. 2023;22(8):2141-2375.
- Gritti A, et al. J Cosmet Dermatol. 2025;24(9):e7043
- Urdiales-Gálvez F et al. J Cosmet Dermatol. 2023;22(8):2186-2197.
|
© 2026 AbbVie. All rights reserved. CA-HAR-260063
|
|
|